Current State and Challenges of Pharmacoeconomic Evaluation in Korea.
Sang Eun Choi
J Prev Med Public Health. 2008;41(2):74-79.     DOI:
Citations to this article as recorded by Crossref logo
Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries
Abdulaziz Ibrahim Alzarea, Yusra Habib Khan, Abdullah Salah Alanazi, Muhammad Hammad Butt, Ziyad Saeed Almalki, Abdullah K. AlAhmari, Saud Alsahali, Tauqeer Hussain Mallhi
International Journal of Environmental Research and Public Health.2022; 19(13): 7862.     CrossRef
Barriers to implementing pharmacoeconomics: interview study
Qais Alefan, Esra’a Hamdouni, Hamza Alhamad, Tareq Mukattash, Karen Rascati
Expert Review of Pharmacoeconomics & Outcomes Research.2021; 21(1): 93.     CrossRef
Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea
Syed Shahzad Hasan, Chia Siang Kow, Dalia Dawoud, Omneya Mohamed, Darrin Baines, Zaheer-Ud-Din Babar
Value in Health Regional Issues.2019; 18: 18.     CrossRef